However, our study also has some shortcomings, such as the lack of a significant suppression of AHR in the first Pam3Cys treatment protocol and the lack of histological evaluation of mucus production in all our experiments, which precludes any conclusions to be drawn on this highly relevant asthma parameter. This evidence concerns the gene AHR and asthma.